Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer
(Q57693562)
scientific article published on 01 February 2005
scientific article published on 01 February 2005
Language:
Current Data About
Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer
other details
description | scientific article published on 01 February 2005 |
External Links
(P356) |
10.1200/JCO.2005.05.274
|
(P698) |
15718346
|